The Agency vs DDSmatch Franchise

The Agency is the stronger target right now, and it comes down to TAM and timing. With 106 total units and 77 franchised locations—nearly double DDSmatch on both counts—you’re looking at a materially larger near-term deal pipeline. A 6% royalty signals operators are doing enough volume to absorb ongoing software spend, and the 2026 FDD filing means management is current, compliant, and likely making active technology decisions during this disclosure period. More units buying today beats fast growth you have to wait to monetize.

Budget terrain slightly favors DDSmatch thanks to a higher initial franchise fee ($125K) and a tighter, lower-mid-range investment band that doesn’t balloon up to $896K like The Agency’s high end—suggesting a more uniform, cookie-cutter tech stack across locations. The 2% ad fund is also marginally higher, hinting at shared operational intensity. But that advantage gets hollowed out when you’ve only got 41 units to sell into, 21% unit growth on a tiny base is noise, and the filing is already past due. You can’t build a territory on 40 franchised doors with stale FDD data.

The tradeoff is concentration risk: The Agency’s wide investment range ($120K–$896K) signals heterogeneous operator profiles, which means your software won’t be a one-size-fits-most sale. Some franchisees will be lean solo agents, others full brokerages with heavy back-office needs—requiring sharper segmentation. That’s a terrain challenge, not a disqualifier. TAM scale and a current FDD cycle create urgency and volume DDSmatch simply can’t match.

Verdict: The Agency wins on TAM and timing; its broader unit base and current filing status make it the higher-opportunity play right now, despite a narrower procurement-budget fit.